MDA-MB-468

Information for MDA-MB-468

Description

Homo sapiens (human) mammary gland adenocarcinoma cell line. It was isolated in 1977 by R. Cailleau, et al., from a pleural effusion of a 51-year-old Black female patient with metastatic adenocarcinoma of the breast.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
2
Transcriptional Factors
2
Peaks
70,527
Non-redundant peaks
66,112

Description

Cell_name
MDA-MB-468
Category
Cancer cell line
Disease
NCIt; C5214; Breast adenocarcinoma
Sex_gender_of_cell
Female
Age_of_donor
51Y

External IDs

Cellosaurus
CVCL_0419
Experimental Factor
EFO_0001216
BRENDA Tissue
BTO:0001570
Wiki
MDA-MB-468
ATCC
MDA-MB-468
Synonyms
MB468; MD Anderson-Metastatic Breast-468; MDA-468; MDA-MB 468; MDA-MB468; MDA468; MDAMB468
All peaks MDA-MB-468
Download BED file
Non redundant MDA-MB-468
Download BED file
CRMs MDA-MB-468
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for MDA-MB-468

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
MDA-MB-468 MAX GEO Homo sapiens GSE81381 Download (31,789)
MDA-MB-468 EtOH STAT3 GEO Homo sapiens GSE85579 Download (38,738)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.